| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1274 | 2018 |
| Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ... The Lancet Infectious Diseases 21 (6), e149-e162, 2021 | 738 | 2021 |
| Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006) O Leroy, JP Gangneux, P Montravers, JP Mira, F Gouin, JP Sollet, J Carlet, ... Critical care medicine 37 (5), 1612-1618, 2009 | 730 | 2009 |
| Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey A Cornillet, C Camus, S Nimubona, V Gandemer, P Tattevin, C Belleguic, ... Clinical Infectious Diseases 43 (5), 577-584, 2006 | 437 | 2006 |
| Invasive fungal diseases during COVID-19: we should be prepared JP Gangneux, ME Bougnoux, E Dannaoui, M Cornet, JR Zahar Journal de mycologie medicale 30 (2), 100971, 2020 | 378 | 2020 |
| Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007) O Lortholary, JP Gangneux, K Sitbon, B Lebeau, F De Monbrison, ... Clinical microbiology and infection 17 (12), 1882-1889, 2011 | 369 | 2011 |
| The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries M Hoenigl, D Seidel, A Carvalho, SM Rudramurthy, A Arastehfar, ... The Lancet Microbe 3 (7), e543-e552, 2022 | 356 | 2022 |
| A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units P Montravers, JP Mira, JP Gangneux, O Leroy, O Lortholary, ... Clinical microbiology and infection 17 (7), 1061-1067, 2011 | 247 | 2011 |
| COVID-19–associated pulmonary aspergillosis, March–August 2020 J Salmanton-García, R Sprute, J Stemler, M Bartoletti, D Dupont, ... Emerging infectious diseases 27 (4), 1077, 2021 | 213 | 2021 |
| Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study JP Gangneux, E Dannaoui, A Fekkar, CE Luyt, F Botterel, N De Prost, ... The Lancet Respiratory Medicine 10 (2), 180-190, 2022 | 208 | 2022 |
| Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the … JF Timsit, E Azoulay, C Schwebel, PE Charles, M Cornet, B Souweine, ... Jama 316 (15), 1555-1564, 2016 | 199 | 2016 |
| Diagnosing COVID-19-associated pulmonary aspergillosis PE Verweij, JP Gangneux, M Bassetti, RJM Brüggemann, OA Cornely, ... The Lancet Microbe 1 (2), e53-e55, 2020 | 192 | 2020 |
| Fungal contamination of food in hematology units A Bouakline, C Lacroix, N Roux, JP Gangneux, F Derouin Journal of clinical microbiology 38 (11), 4272-4273, 2000 | 175 | 2000 |
| ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries SM Rudramurthy, M Hoenigl, JF Meis, OA Cornely, V Muthu, ... Mycoses 64 (9), 1028-1037, 2021 | 171 | 2021 |
| Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of … J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ... Clinical Microbiology and Infection 28 (4), 580-587, 2022 | 169 | 2022 |
| Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis F Lanternier, S Poiree, C Elie, D Garcia-Hermoso, P Bakouboula, ... Journal of Antimicrobial Chemotherapy 70 (11), 3116-3123, 2015 | 168 | 2015 |
| Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. A Paugam, J Dupouy-Camet, P Blanche, JP Gangneux, ... | 136 | 1994 |
| Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study F Robert-Gangneux, S Belaz, M Revest, P Tattevin, S Jouneau, O Decaux, ... Journal of clinical microbiology 52 (9), 3370-3376, 2014 | 135 | 2014 |
| Indoor fungal contamination: health risks and measurement methods in hospitals, homes and workplaces D Méheust, P Le Cann, G Reboux, L Millon, JP Gangneux Critical Reviews in Microbiology 40 (3), 248-260, 2014 | 124 | 2014 |
| Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi AM Borman, MD Palmer, L Delhaes, J Carrère, L Favennec, S Ranque, ... Sabouraudia 48 (Supplement_1), S88-S97, 2010 | 122 | 2010 |
